Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
This is a 166.7% increase over the number of companies inspected in the previous quarter, when three companies received three inspections.
Most of the companies inspected at the time were involved in the Biologics sector. Both the Drugs and Food and Cosmetics sectors sectors tied for second most common type.
There were seven companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Adventist Healthcare | Biologics | 02/22/2024 | No Action Indicated (NAI) |
| American Red Cross Diagnostic Manufacturing Division | Biologics | 02/13/2024 | No Action Indicated (NAI) |
| AstraZeneca Pharmaceuticals LP | Drugs | 01/22/2024 | No Action Indicated (NAI) |
| Montgomery Women's Medical Center, PC | Biologics | 01/17/2024 | No Action Indicated (NAI) |
| Nutricia North America | Food and Cosmetics | 01/30/2024 | No Action Indicated (NAI) |
| SUCO, Inc. | Drugs | 02/25/2024 | Voluntary Action Indicated (VAI) |
| Susan L. Stramer, PhD | Biologics | 01/24/2024 | No Action Indicated (NAI) |
| Vaccaro's, Inc. | Food and Cosmetics | 02/26/2024 | No Action Indicated (NAI) |
Alerts Sign-up